Likewise, Ser181 phosphorylation of oncogenic KRas was involved in tumour growth after subcutaneous injection of NIH3T3 fibroblasts or the colorectal cancer cell line DLD1 stably expressing phosphomimetic and non-phosphorylatable KRas mutants in nude mice [172]. Here, KRAS is linked to neoplasm.